Can we eradicate a second human disease?

Madeleine Finlay sits down with co-host and science editor Ian Sample to discuss three eye-catching stories from the week, including a review into the effectiveness of a new class of Alzheimer’s drug that was once hailed as a game-changer in slowing the progress of the disease. A ...  Show more

Alongside the oil and gas stranded in the strait of Hormuz is another commodity vital to today’s economy: helium. It is a critical element in all kinds of areas from MRI machines to the Large Hadron Collider, and even deep-sea diving. It is also integral to the AI boom. And this ...  Show more

Verge senior AI reporter Hayden Field and New York Times reporter Kashmir Hill discuss the significant mental health impact AI chatbots, such as ChatGPT, can have on users — both people in crisis, and also people who seemed stable. This episode contains non-detailed discussions o ...  Show more

Today I talked with Stijn Vanheule about Why Psychosis Is Not So Crazy: A Road Map to Hope and Recovery for Families and Caregivers (Other Press, 2024). Are we all a little crazy? Roughly 15 percent of the population will have a psychotic experience, in which they lose contact wi ...  Show more

I’ve had the privilege of talking to many brilliant people about artificial intelligence. And when you ask them to imagine the most beneficial consequences of this technology, they almost always give the same answer: medicine. The dream is dazzling. Superintelligent AI will cure ...  Show more

In this episode, Dr. Puder addresses the fascinating realm of schizophrenia with Dr. Cummings, a previous guest in the show. Dr. Cummings is a psychiatrist with a wealth of experience from working at Patton State Hospital in California, one of the biggest forensic hospitals in th ...  Show more